Working to develop the scientific basis for a permanent regulatory framework for anthroposophic medicinal products in Europe

ESCAMP publications alphabetic

  1. Arendt A, Debus M, Karutz M, Kienle GS, Kuck A, Kummer K-R, et al. Vademecum Anthroposophische Arzneimittel, 4. deutsche, überarbeitete und erweiterte Auflage. Band 2. Merkurstab 2017;70(5, Supplement).
  2. Arendt A, Debus M, Karutz M, Kienle GS, Kuck A, Kummer K-R, et al. Vademecum Anthroposophische Arzneimittel, 4. deutsche, überarbeitete und erweiterte Auflage. Band 1. Merkurstab 2017;70(5, Supplement).
  3. Arendt A, Debus M, Karutz M, Kienle GS, Kuck A, Kummer K-R, et al. Vademecum of Anthroposophic Medicines. Third English edition. Merkurstab 2017;70(2 Supplement):1436.
  4. Baars EW, Kienle GS, Heusser P, Pedersen PA, van Wietmarschen HA, Kiene H, von Schön-Angerer T, Hamre HJ. Anthroposophic Medicinal Products: A literature review of reatures, similarities and differences to Conventional Medicinal Products, scientific and regulatory assessment. Global Adv Health Med 2022;11(1):1-17. DOI:
  5. Baars EW, Kiene H, Kienle GS, Heusser P, Hamre HJ. An assessment of the scientific status of anthroposophic medicine, applying criteria from the philosophy of science. Complement Ther Med 2018(40),145-150.
  6. Baars E, Koster E, Schoorel E. Client experiences with an integrated conventional and anthroposophic approach at the "Kindertherapeuticum" in Zeist. Merkurstab 2012;65(4):335-338.
  7. Baars EW, Adriaansen-Tennekes R, Eikmans KJ. Safety of homeopathic injectables for subcutaneous administration: a documentation of the experience of prescribing practitioners. J Altern Complement Med 2005;11(4):609-16.
  8. Baars EW, Bruin AD. The effect of Gencydo injections on hayfever symptoms: a therapeutic causality report. J Altern Complement Med 2005;11(5):863-9.
  9. Baars EW, Gans S, Ellis EL. The effect of hepar magnesium on seasonal fatigue symptoms: a pilot study. J Altern Complement Med 2008;14(4):395-402.
  10. Baars EW, Hamre HJ. Whole medical systems versus the system of conventional biomedicine: a critical, narrative review of similarities, differences, and factors that promote the integration process. Evid Based Complement Alternat Med 2017
  11. Baars EW, Jong M, Nierop AF, Boers I, Savelkoul HF. Citrus/Cydonia compositum subcutaneous injections versus nasal spray for seasonal allergic rhinitis: a randomized controlled trial on efficacy and safety. ISRN Allergy 2011.
  12. Baars EW, Jong MC, Boers I, Nierop AF, Savelkoul HF. A comparative in vitro study of the effects of separate and combined products of Citrus e fructibus and Cydonia e fructibus on immunological parameters of seasonal allergic rhinitis. Mediators Inflamm 2012.
  13. Baars EW, Kooreman P. A 6-year comparative economic evaluation of healthcare costs and mortality rates of Dutch patients from conventional and CAM GPs. BMJ Open 2014;4(8):e005332.
  14. Baars EW, Koster EB, Verhoef J. The contribution of anthroposophic medicine to self-management: an exploration of concepts, evidence, and patient perspectives. Complement Med Res 2017;24(4):225-31.
  15. Baars EW, Nierop AF, Savelkoul HF. Development of systems biology-oriented biomarkers by permuted stepwise regression for the monitoring of seasonal allergic rhinitis treatment effects. J Immunol Methods 2012;378(1-2):62-71.
  16. Baars EW, Nierop AFM, and Savelkoul HFJ, Seasonal allergic rhinitis and systems biology-oriented biomarker discovery. In: (Preedy VR, Patel VB, editors) General methods in biomarker research and their application. Berlin: Springer, 2015. p. 1251-1275
  17. Baars EW, Savelkoul HF. Citrus/Cydonia comp. can restore the immunological balance in seasonal allergic rhinitis-related immunological parameters in vitro. Mediators Inflamm 2008.
  18. Baars EW. A philosophical foundation of anthroposophical medicine. In: van der Bie G, Huber M (editors). Foundations of Anthroposophical Medicine: A training manual. Edinburgh: Floris Books; 2003. p. 47-68.
  19. Baars EW. The benefit/risk balance of subcutaneous injections as used in homeopathy and anthroposophic medicine: A narrative literature review. Eur J Integr Med 2017;15:1-9.
  20. Baumgartner S, Shah D, Schaller J, Kämpfer U, Thurneysen A, Heusser P. Reproducibility of dwarf pea shoot growth stimulation by homeopathic potencies of giberellic acid. Complement Ther Med 2008;16(4):183-91.
  21. Baumgartner S, Thurneysen A, Heusser P. Growth stimulation of dwarf peas (Pisum sativum L.) through homeopathic potencies of plant growth substances. Forsch Komplementärmed Klass Naturheilkd 2004;11:281-92.
  22. Baumgartner S, Wolf M, Skrabal P, Bangerter F, Heusser P, Thurneysen A, Wolf U. High-field 1H T1 and T2 NMR relaxation time measurements of H2O in homeopathic preparations of quartz, sulfur, and copper sulfate. Naturwissenschaften 2009;96(9):1079-89.
  23. Breitkreuz T, Bopp A. Lowering high blood pressure: The three-type holistic approach. Edinburgh: Floris Books; 2014. 128 p
  24. Burkhart J, Wälchli C, Heusser P, Weissenstein U, Baumgartner S, Andres AC. In vitro investigation into the potential of a mistletoe extract to alleviate adverse effects of cyclophosphamide. Altern Ther Health Med 2010;16(3):40-8.
  25. Büssing A, Hirdes AT, Baumann K, Hvidt NC, Heusser P: Aspects of spirituality in medical doctors and their relation to specific views of illness and dealing with their patients' individual situation. Evid Based Complement Alternat Med 2013.
  26. Büssing A, Ostermann T, Heusser P, Matthiessen PF. Usage of alternative medical systems, acupuncture, homeopathy and anthroposophic medicine, by older German adults. Zhong Xi Yi Jie He Xue Bao 2011;9(8):847-56.
  27. Derbidge R, Baumgartner S, Heusser P. Mistletoe berry outline mapping with a path curve function and recording the circadian rhythm of their phenotypic shape change. Front Plant Sci 2016; 7.
  28. Esch BM, Marian F, Busato A, Heusser P. Patient satisfaction with primary care: an observational study comparing anthroposophic and conventional care. Health Qual Life Outcomes 2008;6(1):74.
  29. Estko M, Baumgartner S, Urech K, Kunz M, Regueiro U, Heusser P, Weissenstein U. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro. BMC Complement Altern Med 2015, 15:130.
  30. Evans M, Roger I. Healing for body, soul and spirit – An introduction to anthroposophical medicine. Edinburgh: Floris Books; 2013, 192 p.
  31. Evans M, Zimmermann P. Internationale prospektive Beobachtungsstudie zur Verschreibung Anthroposophischer Arzneimittel: Dokumentation des Therapieerfolges durch Patient und Arzt. Merkurstab 2005;58(2):88-97.
  32. Fintelmann V, Treichler M, Kienle GS, (editors). Onkologie auf anthroposophischer Grundlage. Band 4: Methodologie und Wirksamkeitsnachweis der anthroposophischen Krebstherapie. Frankfurt am Main: Info3 Verlag, 2016, 238 p.
  33. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 2014;67(1):46-51.
  34. Guggisberg AG, Baumgartner S, Tschopp CM, Heusser P. Replication study concerning the effects of homeopathic dilutions of histamine on human basophil degranulation in vitro. Complement Ther Med 2005;13:91-100.
  35. Hamre HJ, Glockmann A, Marti J, Soldner G. Mapping physicians’ experiences with medicinal products from whole medical systems: A descriptive analysis of the Vademecum of Anthroposophic Medicines. Complement Med Res 2020;
  36. Hamre HJ, Pham VN, Kern C, Rau R, Klasen J, Schendel U, Gerlach L, Drabik A, Simon L. A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs vs. conventional therapy including DMARDs for patients without preference. Patient Preference and Adherence 2018; 12: 375-97
  37. Hamre HJ, Fischer M, Heger M, Riley D, Haidvogl M, Baars E, et al. Anthroposophic vs. conventional therapy of acute respiratory and ear infections: a prospective outcomes study. Wien Klin Wochenschr 2005;117(7-8):256-68.
  38. Hamre HJ, Glockmann A, Fischer M, Riley DS, Baars E, Kiene H. Use and safety of anthroposophic medications for acute respiratory and ear infections: a prospective cohort study. Drug Target Insights 2007;2:209-19.
  39. Hamre HJ, Glockmann A, Heckenbach K, Matthes H. Use and safety of anthroposophic medicinal products: an analysis of 44,662 patients from the EvaMed Pharmacovigilance Network. Drugs - Real World Outcomes 2017;4(4):199-213.
  40. Hamre HJ, Glockmann A, Kienle GS, Kiene H. Combined bias suppression in single-arm therapy studies. J Eval Clin Pract 2008;14(5):923-9.
  41. Hamre HJ, Glockmann A, Schwarz R, Riley DS, Baars EW, Kiene H, et al. Antibiotic use in children with acute respiratory or ear infections: prospective observational comparison of anthroposophic and conventional treatment under routine primary care conditions. Evid Based Complement Alternat Med 2014.
  42. Hamre HJ, Glockmann A, Tröger W, Kienle GS, Kiene H. Assessing the order of magnitude of outcomes in single-arm cohorts through systematic comparison with corresponding cohorts: an example from the AMOS study. BMC Med Res Methodol 2008;8(11).
  43. Hamre HJ, Kiene H, Glockmann A, Ziegler R, Kienle GS. Long-term outcomes of anthropo-sophic treatment for chronic disease: a four-year follow-up analysis of 1510 patients from a prospective observational study in routine outpatient settings. BMC Res Notes 2013;6(269).
  44. Hamre HJ, Kiene H, Kienle GS. Clinical research in anthroposophic medicine. Altern Ther Health Med 2009;15(6):52-5.
  45. Hamre HJ, Kiene H, Ziegler R, Tröger W, Meinecke C, Schnürer C, et al. Overview of the publications from the Anthroposophic Medicine Outcomes Study (AMOS) - a whole system evaluation study. Global Adv Health Med 2014;3(1):54-70.
  46. Hamre HJ, Mittag I, Glockmann A, Kiene H, Tröger W. Pulpa dentis D30 for acute reversible pulpitis: A prospective cohort study in routine dental practice. Altern Ther Health Med 2011;17(1):16-21.
  47. Hamre HJ, Witt CM, Glockmann A, Tröger W, Willich SN, Kiene H. Use and safety of anthroposophic medications in chronic disease: a 2-year prospective analysis. Drug Saf 2006;29(12):1173-89.
  48. Hamre HJ, Witt CM, Glockmann A, Wegscheider K, Ziegler R, Willich SN et al. Anthroposoph-ic -vs. conventional therapy for chronic low back pain: a prospective comparative study. Eur J Med Res 2007; 12:302-310.
  49. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Kienle GS, Willich SN, et al. Outcome of anthroposophic medication therapy in chronic disease: A 12-month prospective cohort study. Drug Des Devel Ther 2008;2:25-37.
  50. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Kienle GS, Willich SN, et al. Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings. Eur J Health Econ 2010;11(1):77-94.
  51. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Willich SN, Kiene H. Anthroposophic therapy for chronic depression: a four-year prospective cohort study. BMC Psychiatry 2006(57),
  52. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Willich SN, Kiene H. Health costs in anthroposophic therapy users: a two-year prospective cohort study. BMC Health Serv Res 2006;6(65).
  53. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Willich SN, Kiene H. Predictors of outcome after 6 and 12 months following anthroposophic therapy for adult outpatients with chronic disease: a secondary analysis from a prospective observational study. BMC Res Notes 2010;3(218).
  54. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Ziegler R, Rivoir A, et al. Anthroposophic therapy for migraine: a two-year prospective cohort study in routine outpatient settings. Open Neurol J 2010;4:100-10.
  55. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Ziegler R, Willich SN, Kiene H. Long-term out-comes of anthroposophic therapy for chronic low back pain: A two-year follow-up analysis. J Pain Res 2009;2:75-85.
  56. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Ziegler R, Willich SN, et al. Anthroposophic therapy for anxiety disorders: a two-year prospective cohort study in routine outpatient settings. Clin Med Psychiatr 2009;2:17-31.
  57. Hamre HJ, Witt CM, Kienle GS, Meinecke C, Glockmann A, Willich SN, Kiene H. Anthroposophic therapy for children with chronic disease: a two-year prospective cohort study in routine outpatient settings. BMC Pediatr 2009, 9(39),
  58. Hamre HJ, Witt CM, Kienle GS, Meinecke C, Glockmann A, Ziegler R, et al. Anthroposophic therapy for attention deficit hyperactivity: a two-year prospective study in outpatients. Int J Gen Med 2010;3:239-53.
  59. Hamre HJ, Witt CM, Kienle GS, Schnürer C, Glockmann A, Ziegler R, Willich SN, Kiene H. Anthroposophic therapy for asthma: a two-year prospective cohort study in routine outpatient settings. J Asthma Allergy 2009:2:111-128.
  60. Hamre HJ. Scientific relevance of the Vademecum of Anthroposophic Medicines. Merkurstab 2018(2);71(2):120-4.  or full text PDF
  61. Hamre HJ. Bedeutung des Vademecum-Projekts. Merkurstab, 2017;70(6):482-486.
  62. Heinz J, Fiori W, Heusser P, Ostermann T. Cost analysis of integrative inpatient treatment based on DRG data: The example of Anthroposophic Medicine. Evid Based Complement Alternat Med 2013.
  63. Heusser P, Berger Braun S, Ziegler R, Bertschy M, Burkard R, Ziegler R, Helwig S, van Wegberg B, Cerny T. Palliative in-patient cancer treatment in an anthroposophic hospital: II. Quality of life during and after stationary treatment, and subjective treatment benefits. Forsch Komplementärmed 2006;13:156-66.
  64. Heusser P, Berger Braun S, Ziegler R, Bertschy M, Helwig S, van Wegberg B, Cerny T. Palliative in-patient cancer treatment in an anthroposophic hospital: I. Treatment patterns and compliance with anthroposophic medicine. Forsch Komplementärmed 2006;13:94-100.
  65. Heusser P, Berger S, Stutz M, Hüsler A, Haeberli A, Wolf U: Efficacy of homeopathically potentized antimony on blood coagulation. A randomized placebo controlled crossover trial. Forsch Komplementmed 2009;16(1):14-8.
  66. Heusser P, Kienle GS. Anthroposophic medicine, integrative oncology, and mistletoe therapy of cancer. In: Abrams D, Weil A (editors.): Integrative Oncology. 2nd edition. New York: Oxford University Press, 2014, pp. 560-78.
  67. Heusser P, Stutz M, Haeberli A. Does homeopathically potentized antimony stimulate coagulation? A summary of previous findings and results of an in vitro pilot study by means of thrombelastography. J Altern Complem Med 2004;10(5):829-34.
  68. Heusser P. Anthroposophy and science - an introduction. New York: Peter Lang; 2016, 368 p.
  69. Heusser P. East meets West – but bridging concepts are still lacking. Forsch Komplementärmed 2015;22:285-287.
  70. Heusser P. Scheffer C. Neumann M. Tauschel D. Edelhauser F. Towards non-reductionistic medical anthropology, medical education and practitioner-patient-interaction: the example of Anthroposophic Medicine. Patient Educ Couns 2012;89(3)455-60.
  71. Jäger T, Scherr C, Shah D, Majewsky V, Betti L, Trebbi G, Bonamin L, Simoes-Wüst AP, Wolf U, Simon M, Heusser P, Baumgartner S: Use of homeopathic preparations in abiotically stressed plants. Homeopathy 2011;100:275-87.
  72. Jäger T, Scherr C, Simon M, Heusser P, Baumgartner S: Effects of homeopathic arsenicum album, nosode, and gibberellic acid preparations on the growth rate of arsenic-impaired duckweed (Lemna gibba L.). Scientific World J 2010;10: 2112-29.
  73. Jäger T, Scherr C, Wolf U, Simon M, Heusser P, Baumgartner S: Investigation of arsenic-stressed yeast (saccharomyces cerevisiae) as a bioassay in homeopathic basic research. Scientific World J 2011;558-83.
  74. Jong MC, van Wietmarschen H, Glockmann A, Baars EW, Hamre HJ. Safety of Anthroposophic Medicinal Products: An analysis of adverse drug reactions from German pharmacovigilance databases. Drugs - Real World Outcomes 2021.
  75. Jong MC, Jong MU, Baars EW. Adverse drug reactions to anthroposophic and homeopathic solutions for injection: a systematic evaluation of German pharmacovigilance databases. Pharmacoepidemiol Drug Saf 2012;21(12):1295-301.
  76. Kiene H, Hamre HJ, Kienle GS. In support of clinical case reports: a system of causality assessment. Glob Adv Health Med 2013;2(2):64-75.
  77. Kienle GS, Albonico HU, Baars E, Hamre HJ, Zimmermann P, Kiene H. Anthroposophic medicine: an integrative medical system originating in Europe. Glob Adv Health Med 2013;2(6):20-31.
  78. Kienle GS, Albonico HU, Fischer L, Frei-Erb M, Hamre HJ, Heusser P, et al. Complementary therapy systems and their integrative evaluation. Explore (NY) 2011;7(3):175-87.
  79. Kienle GS, Berrino F, Büssing A, Portalupi E, Rosenzweig S, Kiene H. Mistletoe in cancer - a systematic review on controlled clinical trials. Eur J Med Res 2003;8(3):109-19.
  80. Kienle GS, Glockmann A, Grugel R, Hamre HJ, Kiene H. Klinische Forschung zur Anthroposophischen Medizin - Update eines Health Technology Assessment-Berichts und Status Quo [Clinical research on anthroposophic medicine: update of a health technology assessment report and status quo]. Forsch Komplementärmed 2011:18; 269-82.
  81. Kienle GS, Glockmann A, Schink M, Kiene H. Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. J Exp Clin Cancer Res 2009;28:79.
  82. Kienle GS, Grugel R, Kiene H. Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters. BMC Complement Altern Med 2011;11(1):72
  83. Kienle GS, Hamre HJ, Kiene H, Ostermann T, Anderle L, Maussner N, et al. Methodological aspects of integrative and person-oriented health care evaluation. Complement Med Res 2017;24(Suppl 1):23-8.
  84. Kienle GS, Kiene H, Albonico HU. Anthroposophic medicine: effectiveness, utility, costs, safety. Stuttgart, New York: Schattauer Verlag; 2006. 350 p.
  85. Kienle GS, Kiene H. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res 2007;12(3):103-19.
  86. Kienle GS, Kiene H. Die Mistel in der Onkologie - Fakten und konzeptionelle Grundlagen. Stuttgart: Schattauer Verlag; 2003, 749 p.
  87. Kienle GS, Kiene H. From reductionism to holism: Systems-oriented approaches in cancer research. Global Adv Health Med 2012;1(5):68-77.
  88. Kienle GS, Kiene H. Klinische Studien zur Misteltherapie der Krebserkrankung – Eine Übersicht. Merkurstab 2017;70(3):176-86.
  89. Kienle GS, Kiene H. Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther 2010;9(2):142-57.
  90. Kienle GS, Meusers M, Quecke B, Hilgard D. Patient-centered diabetes care in children: an integrated, individualized, systems-oriented, and multidisciplinary approach. Glob Adv Health Med 2013;2(2):12-9.
  91. Kienle GS, Mussler M, Fuchs D, Kiene H. Individualized integrative cancer care in anthroposophic medicine: a qualitative study of the concepts and procedures of expert doctors. Integr Cancer Ther 2016;15(4):478-94.
  92. Kienle GS, Mussler M, Fuchs D, Kiene H. Intravenous mistletoe treatment in integrative cancer care: a qualitative study exploring the procedures, concepts, and observations of expert doctors. Evid Based Complement Alternat Med;2016.
  93. Kienle GS. Why medical case reports? [Editorial]. Glob Adv Health Med 2012;1(1):8-9.
  94. Kooreman P, Baars EW. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Eur J Health Econ 2012;13(6):769-76.
  95. Koster EB, Ong RR, Heybroek R, Delnoij DM, Baars EW. The consumer quality index anthroposophic healthcare: a construction and validation study. BMC Health Serv Res 2014;14(1):148.
  96. Kröz M, Kienle GS, Feder G, Kaveri S, Rosenzweig S. Mistletoe: from basic research to clinical outcomes in cancer and other indications [Editorial]. Evid Based Compl Alternat Med 2014
  97. Lahnstein L, Binder M, Thurneysen A, Frei-Erb M, Betti L, Peruzzi M, Heusser P, Baumgartner S. Isopathic treatment effects of Arsenicum album 45x on wheat seedling growth - further reproduction trials. Homeopathy 2009;98(4):198-207.
  98. Marschollek B, Nelle M, Wolf M, Baumgartner S, Heusser P, Wolf U. Effects of exposure to physical factors on homeopathic preparations as determined by ultraviolet light spectroscopy. Scientific World J 2010;10:49-61.
  99. Meyer U, Pedersen PA (editors): Anthroposophische Pharmazie - Grundlagen, Herstellerprozesse, Arzneimittel. Berlin: Salumed Verlag; 2016, 807 p.
  100. Orange M, Lace A, Fonseca MP, von Laue BH, Geider S, Kienle GS. Durable regression of primary cutaneous B-cell lymphoma following fever-inducing mistletoe treatment: two case reports. Glob Adv Health Med 2012;1(1):18-25.
  101. Pedersen PA, Straub M, Walle EM. Vegetabilisierte Metalle Teil II. Anbau der Pflanzen und Herstellung der Tinkturen [Vegetabilised Metals—Cultivation of the plants and manufacture of the tinctures]. Merkurstab 2013,66(1):18-23.
  102. Pedersen PA, Ziolkowski J. Hintergründe und Praxis des Rh-Verfahrens [Background to and method of the Rh process]. Merkurstab 2014, 67(6):473-81.
  103. Pedersen PA. Über die Entstehung und Weiterentwicklung der anthroposophischen Arzneimittel. Wie geht es weiter? Eine persönliche Sichtweise. Merkurstab 2004,57(4):294-7.
  104. Pedersen PA. Von den Spuren des Kupfers in Kultur und Natur. Merkurstab 2011;64(5):480-5.
  105. Pedersen PA. Zur Bedeutung der pharmazeutischen Prozesse am Beispiel des Kiesels. Merkurstab 2008,61(1):48-53.
  106. Ponstein AS, Zwart CA, van Gerven M, Baars EW. The development of an anthroposophic, whole medical system, healthcare program for patients with depressive disorders. J Altern Compl Med (New York, NY) 2017.
  107. Riley DS, Barber MS, Kienle GS, Aronson J, von Schoen-Angerer T, Tugwell P, et al. CARE 2013 explanations and elaborations: reporting guidelines for case reports. J Clin Epidemiol 2017;89:218-235.
  108. Schad F, Teodoridis C, Albrecht U, Merkle A, Baute R, Breitkreuz T, Matthes H: Network Oncology (NO) - a European approach to health service research on cancer treatment with focus on concurrent use of complementary therapies. Eur J Integr Med 2008;1(Suppl 1):12-13.
  109. Shah-Rossi D, Heusser P, Baumgartner S. Homeopathic treatment of Arabidopsis thaliana plants infected with Pseudomonas syringae. Scientific World J 2009;9:320-30.
  110. Soldner G, Sommer M. Autoimmune thyroid diseases and problems in psychological maturation. Merkurstab 2005;57(Engl. Issue):6-13.
  111. Soldner G, Stellmann HM. Individual paediatrics. Physical, emotional and spiritual aspects of diagnosis and counselling. Anthroposophic-homeopathic therapy. 4. ed. Stuttgart: CRC Press; 2014. 984 p.
  112. Soldner G. Neurodermatitis in childhood. Merkurstab 2006;58(Engl. Issue):44-52.
  113. Tröger W, Jezdic S, Zdrale Z, Tisma N, Hamre HJ, Matijasevic M. Quality of life and neutropenia in patients with early stage breast cancer: A randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone. Breast Cancer (Auckl.) 2009; 3:35-45.
  114. Urech K, Büssing A, Thalmann G, Schaefermeyer H, Heusser P. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines. Anticancer Res 2006;26:3049-56.
  115. von Schoen-Angerer T, Goyert A, Vagedes J, Kiene H, Merckens H, Kienle GS. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report. J Gastrointestin Liver Dis 2014;23(4):449-52.
  116. Von Schoen-Angerer T, Madeleyn R, Kiene H, Kienle GS, Vagedes J. Improvement of asthma and gastroesophageal reflux disease with oral Pulvis stomachicus cum Belladonna, a combination of Matricaria recutita, Atropa belladonna, Bismuth, and Antimonite: A pediatric case report. Global Adv Health Med 2016;5(1):107-11.
  117. von Schoen-Angerer T, Wilkens J, Kienle GS, Kiene H, Vagedes J. High-dose viscum album extract treatment in the prevention of recurrent bladder cancer: a retrospective case series. Perm J 2015;19(4):76-83.
  118. Werthmann PG, Helling D, Heusser P, Kienle GS. Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma. BMJ Case Rep 2014;2014.
  119. Werthmann PG, Hintze A, Kienle GS. Complete remission and long-term survival of a patient with melanoma metastases treated with high-dose fever-inducing Viscum album extract: A case report. Medicine (Baltimore) 2017;96(46):e8731.
  120. Werthmann PG, Strater G, Friesland H, Kienle GS. Durable response of cutaneous squamous cell carcinoma following high-dose perilesional injections of Viscum album extracts - a case report. Phytomedicine 2013;20(3-4):324-7.
  121. Wode K, Schneider T, Lundberg I, Kienle GS. Mistletoe treatment in cancer-related fatigue: a case report. Cases J 2009;2(1):77.
  122. Wolf U, Winkler M, Ephraim M, Hamre HJ, Lemann D. The challenge of complexity: Anthroposophic and conventional medicine in dialogue. Primary Care 2011;11(10): 174-175.
  123. Wolf U, Wolf M, Heusser P, Thurneysen A, Baumgartner S. Homeopathic preparations of quartz, sulfur and copper sulfate assessed by UV-spectroscopy. Evid Based Complement Alternat Med 2011.
  124. Wolf U, Wolf M, Heusser P, Thurneysen A, Baumgartner S. Homeopathic preparations of quartz, sulfur, and copper sulfate assessed by UV-spectroscopy. Evid Based Complement Alternat Med 2009.